Photo of Emilio Gonzalez

View Scopus Profile

Emilio Gonzalez, MD

Director, Rheumatology Fellowship Program

  • 1331 Citations
  • 24 h-Index
1982 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Emilio Gonzalez is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

Antiphospholipid Syndrome Medicine & Life Sciences
Systemic Scleroderma Medicine & Life Sciences
Antiphospholipid Antibodies Medicine & Life Sciences
Systemic Lupus Erythematosus Medicine & Life Sciences
Thrombosis Medicine & Life Sciences
Hydroxychloroquine Medicine & Life Sciences
Giant Cell Arteritis Medicine & Life Sciences
Rheumatoid Arthritis Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2007 2019

Protocol N1071F2: "A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade (Infliximab) for the Treatment of Patients with Rheumatoid Arthritis"

Gonzalez, E.

Inventiv Health Clinical

3/6/17 → 3/5/19

Project: Other project

Protocol EMR700461-024: A Phase IIB, Multi-Center, Long-Term Extension Trial to Evaluate the Safety and Tolerability of Atacicept in Subjects with Systemic Lupus Erythematosus (SLE) who Completed Protocol EMR-700461-023 (ADDRESS II)

Gonzalez, E.

EMD Serono Inc

8/26/14 → 8/25/16

Project: Other project

A Phase IIb, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Multidose, 24-Week Study to Evaluate the Efficacy and Safety of Atacicept in Subjects With Systemic Lupus Erythematosus (SLE)

Gonzalez, E.

EMD Serono Inc

7/28/14 → 7/27/16

Project: Other project

Laboratory Services Portion of Protocol Study ALXN1007-APS-201

Gonzalez, E.

Quintiles, Inc.

2/6/14 → 11/17/17

Project: Other project

An Open-Label Proof of Concept Phase IIa Trial of ALXN1007 for the Treatment of Non-criteria Manifestationsof Antiphospholipid Syndrome

Gonzalez, E.

Quintiles, Inc.

2/4/14 → 11/17/17

Project: Other project

Research Output 1982 2019

  • 1331 Citations
  • 24 h-Index
  • 76 Article
  • 1 Chapter
  • 1 Letter
2 Citations (Scopus)

Oral administration of Domain-I of beta-2glycoprotein-I induces immunological tolerance in experimental murine antiphospholipid syndrome

Shemer, A., Willis, R., Gonzalez, E., Romay-Penabad, Z., Shovman, O., Shoenfeld, Y., Blank, M. & Amital, H., May 1 2019, In : Journal of Autoimmunity. 99, p. 98-103 6 p.

Research output: Contribution to journal › Article

Antiphospholipid Syndrome
Oral Administration
Anti-Inflammatory Agents
Cytokines
Immunomodulation

The adjusted global antiphospholipid syndrome score (aGAPSS)and the risk of recurrent thrombosis: Results from the APS ACTION cohort

APS ACTION, Jan 1 2019, (Accepted/In press) In : Seminars in Arthritis and Rheumatism.

Research output: Contribution to journal › Article

Antiphospholipid Syndrome
Thrombosis
Antiphospholipid Antibodies
Registries
Venous Thrombosis
15 Citations (Scopus)

Hydroxychloroquine in the primary thrombosis prophylaxis of antiphospholipid antibody positive patients without systemic autoimmune disease

Erkan, D., Unlu, O., Sciascia, S., Belmont, H. M., Branch, D. W., Cuadrado, M. J., Gonzalez, E., Knight, J. S., Uthman, I., Willis, R., Zhang, Z., Wahl, D., Zuily, S. & Tektonidou, M. G., Mar 1 2018, In : Lupus. 27, 3, p. 399-406 8 p.

Research output: Contribution to journal › Article

Hydroxychloroquine
Antiphospholipid Antibodies
Autoimmune Diseases
Thrombosis
Randomized Controlled Trials
2 Citations (Scopus)

PEGylated Domain I of Beta-2-Glycoprotein I inhibits the binding coagulopathic, and thrombogenic properties of IgG From patients with the antiphospholipid syndrome

McDonnell, T. C. R., Willis, R., Pericleous, C., Ripoll, V. M., Giles, I. P., Isenberg, D. A., Brasier, A. R., Gonzalez, E., Papalardo, E., Romay-Penabad, Z., Jamaluddin, M., Ioannou, Y. & Rahman, A., Oct 22 2018, In : Frontiers in Immunology. 9, OCT, 2413.

Research output: Contribution to journal › Article

beta 2-Glycoprotein I
Antiphospholipid Syndrome
Antiphospholipid Antibodies
Immunoglobulin G
Half-Life
5 Citations (Scopus)

Performance Evaluation and Clinical Associations of Immunoassays That Detect Antibodies to Negatively Charged Phospholipids Other Than Cardiolipin

Castanon, A., Pierre, G., Willis, R., Nigel Harris, E., Papalardo, E., Romay-Penabad, Z., Schleh, A., Jajoria, P., Smikle, M., Deceulaer, K., Tebo, A., Jaskowski, T., Guerra, M. M., Ware Branch, D., Salmon, J. E., Petri, M. & Gonzalez, E., Mar 29 2018, In : American Journal of Clinical Pathology. 149, 5, p. 401-411 11 p.

Research output: Contribution to journal › Article

Cardiolipins
Immunoassay
Phospholipids
Immunoglobulin G
Obstetrics